AstraZeneca has submitted a request to the FDA to allow adults to self-administer its annual flu vaccine, FluMist.
The company's request is based on data from a study that demonstrated the safety and efficacy of self-administration of FluMist.
AstraZeneca, a British-Swedish multinational pharmaceutical and biopharmaceutical company, has submitted a request to the U.S. Food and Drug Administration (FDA) to allow adults to self-administer its annual flu vaccine, FluMist. The vaccine, which is currently administered by healthcare professionals, is a nasal spray that offers an alternative to traditional needle-based flu vaccines.
The company's request, if approved, would mark a significant shift in the way flu vaccines are administered in the United States. It would allow adults to administer the vaccine at home, potentially increasing the accessibility and convenience of flu vaccination.
AstraZeneca's FluMist is a live attenuated influenza vaccine (LAIV) that is currently approved for use in individuals aged 2 to 49. The vaccine is not recommended for pregnant women or individuals with certain health conditions.
The company's request to the FDA is based on data from a study that demonstrated the safety and efficacy of self-administration of FluMist. However, the FDA's decision will be based on a thorough review of the data and consideration of the potential benefits and risks associated with self-administration of the vaccine.
The move by AstraZeneca comes at a time when public health officials are emphasizing the importance of flu vaccination to prevent severe illness and hospitalization. The ability to self-administer the vaccine could potentially increase vaccination rates and reduce the burden on healthcare systems during the flu season.
The company has submitted data from a study of 1,000 adults who self-administered the vaccine, showing that they were able to do so safely and effectively.
Accuracy
No Contradictions at Time
Of
Publication
Deception
(100%)
None Found At Time Of
Publication
Fallacies
(100%)
None Found At Time Of
Publication
Bias
(100%)
None Found At Time Of
Publication
Site
Conflicts
Of
Interest (70%)
Yahoo Finance is owned by Verizon Communications. Verizon has a significant financial interest in the healthcare sector through its subsidiary, Verizon Business Group, which provides telemedicine services.
The company says it has data showing that adults can safely and effectively administer the vaccine to themselves.
Accuracy
No Contradictions at Time
Of
Publication
Deception
(100%)
None Found At Time Of
Publication
Fallacies
(100%)
None Found At Time Of
Publication
Bias
(100%)
None Found At Time Of
Publication
Site
Conflicts
Of
Interest (70%)
CNN is owned by WarnerMedia News & Sports, a division of AT&T's WarnerMedia. AT&T has a significant financial interest in the healthcare sector through its subsidiary, AT&T Business, which provides healthcare solutions.
The company has submitted data from a study of 1,000 adults who self-administered the vaccine, showing that they were able to do so safely and effectively.
The company has submitted data from a study of 1,000 adults who self-administered the vaccine, showing that they were able to do so safely and effectively.
Accuracy
No Contradictions at Time
Of
Publication
Deception
(100%)
None Found At Time Of
Publication
Fallacies
(100%)
None Found At Time Of
Publication
Bias
(100%)
None Found At Time Of
Publication
Site
Conflicts
Of
Interest (70%)
Forbes Media, the parent company of Forbes, has a significant financial interest in the healthcare sector through its Forbes Healthcare division, which hosts healthcare summits and publishes healthcare-related content.
The company has submitted data from a study of 1,000 adults who self-administered the vaccine, showing that they were able to do so safely and effectively.